LENZ Therapeutics Inc (LENZ) Stock Price, Quote, News & History

LENZNASDAQ
$4.91
-0.42-7.88%
At close: Sep 9, 5:00 PM EST
$5.10
0.193.87%
After Hours: 6:25 PM EST

LENZ Therapeutics (LENZ) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-113.91M
Investing Cash Flow (TTM)
-23.23M
Financing Cash Flow (TTM)
123.62M
Free Cash Flow (TTM)
-114.42M
Capital Expenditure (TTM)
-511.00K
Net Change in Cash (TTM)
-13.51M

Analyst Trends and Forecast

2
Mar
1
Apr
2
1
May
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$65.79M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.97
PB Ratio (TTM)
0.70
Earnings Yield % (TTM)
-84.46%
Earnings Yield % (FWD)
-84.66%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.98

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$24.21M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.31
Close
$4.91
Volume / Avg.
705.80K / 852.22K
Day Range
$4.89 - $5.41
52 Wk Range
4.54 - 50.40
Market Cap
$160.24M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
58.61%
Days to Cover
12.53

About

Sector
Health Care
Industry
Pharmaceuticals
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a onc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy LENZ Therapeutics (LENZ) stock?

A

You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are LENZ Therapeutics (LENZ) competitors?

Q

What is the forecast, or price target, for LENZ Therapeutics (LENZ) stock?

A

LENZ Therapeutics has a consensus price target of $30.29.

Q

What is the current price for LENZ Therapeutics (LENZ)?

A

The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $5.1 last updated September 9, 2026 at 6:25 PM EDT.

Q

Does LENZ Therapeutics (LENZ) pay a dividend?

A

There are no upcoming dividends for LENZ Therapeutics.

Q

When is LENZ Therapeutics (NASDAQ:LENZ) reporting earnings?

A

LENZ Therapeutics does not have any upcoming earnings scheduled.

Q

Is LENZ Therapeutics (LENZ) going to split?

A

There is no upcoming split for LENZ Therapeutics.

Q

What sector and industry does LENZ Therapeutics (LENZ) operate in?

A

LENZ Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.